A Barlier

Author PubWeight™ 22.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly. J Clin Invest 2001 1.84
2 A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol 2013 1.15
3 Pituitary stalk interruption syndrome in 83 patients: novel HESX1 mutation and severe hormonal prognosis in malformative forms. Eur J Endocrinol 2011 1.09
4 The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas. Clin Endocrinol (Oxf) 2008 1.01
5 Comparison of [¹¹¹In]pentetreotide-SPECT and [¹⁸F]FDOPA-PET in the localization of extra-adrenal paragangliomas: the case for a patient-tailored use of nuclear imaging modalities. Clin Endocrinol (Oxf) 2011 0.99
6 A novel dysfunctional LHX4 mutation with high phenotypical variability in patients with hypopituitarism. J Clin Endocrinol Metab 2008 0.96
7 Phenotypic homogeneity and genotypic variability in a large series of congenital isolated ACTH-deficiency patients with TPIT gene mutations. J Clin Endocrinol Metab 2011 0.96
8 Pituitary transcription factors: from congenital deficiencies to gene therapy. J Neuroendocrinol 2006 0.95
9 [Clinical and genetic aspects of combined pituitary hormone deficiencies]. Ann Endocrinol (Paris) 2008 0.91
10 Pit-1 gene expression in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab 1994 0.85
11 PROP1 gene screening in patients with multiple pituitary hormone deficiency reveals two sites of hypermutability and a high incidence of corticotroph deficiency. J Clin Endocrinol Metab 2001 0.84
12 A new mutation of the gene encoding the transcription factor Pit-1 is responsible for combined pituitary hormone deficiency. J Clin Endocrinol Metab 1996 0.83
13 Signalling pathway alterations in pituitary adenomas: involvement of Gsalpha, cAMP and mitogen-activated protein kinases. J Neuroendocrinol 2009 0.81
14 Prolactinomas resistant to bromocriptine: long-term efficacy of quinagolide and outcome of pregnancy. Eur J Endocrinol 1996 0.81
15 Demonstration of enhanced potency of a chimeric somatostatin-dopamine molecule, BIM-23A387, in suppressing growth hormone and prolactin secretion from human pituitary somatotroph adenoma cells. J Clin Endocrinol Metab 2002 0.81
16 BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide. J Endocrinol Invest 2005 0.79
17 Conditional overexpression of the wild-type Gs alpha as the gsp oncogene initiates chronic extracellularly regulated kinase 1/2 activation and hormone hypersecretion in pituitary cell lines. Endocrinology 2007 0.79
18 RET gene mutations are not involved in the origin of human testicular seminoma. Int J Androl 2010 0.78
19 Pituitary hormone deficiencies due to transcription factor gene alterations. Growth Horm IGF Res 2004 0.78
20 Relevance of coexpression of somatostatin and dopamine D2 receptors in pituitary adenomas. Mol Cell Endocrinol 2007 0.77
21 Pit-1 gene expression in human lactotroph and somatotroph pituitary adenomas is correlated to D2 receptor gene expression. J Clin Endocrinol Metab 1996 0.77
22 A neonatal form of isolated ACTH deficiency frequently associated with Tpit gene mutations. Endocr Res 2004 0.76
23 The gsp oncogene disrupts Ras/ERK-dependent prolactin gene regulation in gsp inducible somatotroph cell line. Endocrinology 2011 0.76
24 [A cause of intracerebral calcifications that should be known: pseudohypoparathyroidism Ib]. Arch Pediatr 2008 0.76
25 [Genetic aspects of growth hormone deficiency]. Arch Pediatr 2011 0.76
26 New SRIF analogs in the control of human pituitary adenomas: perspectives. J Endocrinol Invest 2005 0.76
27 [Pyomyositis of the lateral vastus muscle in a diabetic female patient]. Ann Med Interne (Paris) 1993 0.75
28 Unusual presentation of multiple endocrine neoplasia type 2A in a patient with the C634R mutation of the RET-protooncogene. Ann Endocrinol (Paris) 2008 0.75
29 Pit-1 gene expression in human pituitary adenomas. Horm Res 1997 0.75
30 [Evaluation of an immunoradiometric assay for succinylated ACTH]. Ann Endocrinol (Paris) 1999 0.75
31 [Genetics of anterior hypopituitary diseases]. Ann Endocrinol (Paris) 2005 0.75
32 [Spontaneous rupture of the splenic artery in an alcoholic diabetic hypertensive woman]. Presse Med 1992 0.75